Heavy AI investments and the tariffs uncertainty have been putting pressure on the technology and growth sector.

As the U.S. stock market faces a sell-off driven by concerns over tariffs and economic uncertainty, investors are increasingly looking for opportunities that can offer resilience and potential growth.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Equities research analysts at StockNews.com assumed coverage on shares of Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Free ...

Auguston kicked off an animated session titled “The People Factor” by outlining all the ways in which the CEO role in ...

ArriVent BioPharma (NASDAQ:AVBP – Get Free Report) is one of 1,068 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its competitors? We ...

Artificial intelligence (AI) and the Internet of Things (IoT) are about to revolutionize the biopharmaceutical industry.

Zydus Lifesciences Ltd on Wednesday (March 12) the company's venture capital arm Zynext Ventures USA LLC has announced an ...

Concentra Biosciences offers $3/share + CVR for Acelyrin, outperforming Alumis' bid. Read why I rate SLRN stock a Sell at ...

PharmaCord is a Jeffersonville, Indiana-based provider of patient services for the biopharmaceutical industry, and Mercalis, a Morrisville, North Carolina-based provider of life sciences and ...

The partnership focuses on enhancing the patient experience by providing greater affordability and access to specialty meds.

The Radnor biopharmaceutical firm Mineralys Therapeutics saw its stock price hit new heights Monday after a positive ...